AI-Driven Risk Intelligence. Proteome-Level Precision. Clinical-Grade Execution.
Cardiovascular disease remains the leading cause of death globally, often progressing silently before acute events such as myocardial infarction or stroke occur. Traditional risk models — while useful — rely heavily on demographic factors and limited laboratory parameters, frequently underestimating individualized risk.
Through our collaboration with Prevencio, a pioneer in AI-powered multi-protein cardiovascular diagnostics, we offer next-generation blood-based cardiovascular risk assessment. Prevencio’s HART® platform integrates validated multi-analyte protein signatures with advanced algorithms to:
- Quantify near-term risk of major adverse cardiovascular events
- Detect obstructive coronary artery disease through non-invasive molecular testing
- Enhance clinical decision-making beyond traditional lipid-centric models
This approach transforms cardiovascular screening from probability estimation to biology-based precision risk stratification.
Complete360® Molecular Depth & Longitudinal Monitoring
At Complete Omics, these cardiovascular biomarker panels are deployed within the Complete360® infrastructure — our ultra-deep, quantitatively harmonized proteomic platform designed for clinical reproducibility.
Complete360® enables:
- High-precision quantification of multi-protein cardiovascular signatures
- Integration of expanded proteomic markers beyond conventional panels
- Longitudinal molecular trajectory tracking for dynamic risk monitoring
- Standardized workflows engineered for clinical-grade consistency
By combining AI-validated cardiovascular algorithms with proteome-level analytical depth, we elevate cardiovascular testing from static risk categorization to continuous molecular surveillance.
CLIA-Certified. CAP-Accredited. Built for Clinical Deployment.
All cardiovascular testing is performed within our CLIA-Certified, CAP-Accredited clinical laboratory, ensuring the highest standards of regulatory compliance, analytical accuracy, and quality control.
Our infrastructure is designed not only for innovation, but for scalable clinical implementation — enabling:
- CPT-coded, insurance-reimbursable testing pathways
- Regulatory-aligned laboratory processes
- Reliable deployment across preventive, primary care, and specialty cardiology settings
By integrating Prevencio’s AI cardiovascular intelligence with the execution discipline of Complete360® under stringent CLIA and CAP oversight, we are advancing a new standard in cardiovascular screening — proactive, quantitative, and molecularly precise.
At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr.